FDA Inspection
Daniel Suez, MDDaniel Suez, MD – FDA Inspection, May 27, 2009
Record Details
This FDA Inspection record concerns Daniel Suez, MD, with an inspection on May 27, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Daniel Suez, MD
- Inspection Date
- May 27, 2009
- Product Type
- Biologics
View Company Profile
ID · 0b7b221e-6e40-4a93-8ae4-891e044f5dff
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 584229
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.62(a)Accountability records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Daniel Suez, MD
1| Date | Classification | Office | Project area |
|---|---|---|---|
| May 13, 2016 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
Other documents for Daniel Suez, MD
- FDA Inspection 975456 - 2016-05-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.